Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Tenaya Therapeutics, Inc. | 120,000 | reported | 28 May 2026 | tx 5+330,659 |
| BRISTOL MYERS SQUIBB CO | 48,335.71 | reported | 01 Feb 2013 | tx 27+42,470.32 |
| LABCORP HOLDINGS INC. | 8,120 | reported | 07 Feb 2024 | tx 108+64,310−55,310 |
| AMGEN INC | 6,240 | reported | 19 May 2023 | tx 20+9,740−3,500 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 28 May 2026 | GRANT_AWARD | Tenaya Therapeutics, Inc. | 120,000 | 0.00 USD | deriv |
| 29 May 2025 | GRANT_AWARD | Tenaya Therapeutics, Inc. | 107,400 | 0.00 USD | deriv |
| 18 Oct 2024 | GRANT_AWARD | Tenaya Therapeutics, Inc. | 34,000 | 0.00 USD | deriv |
| 07 Feb 2024 | EXERCISE | LABCORP HOLDINGS INC. | 947 | — | |
| 06 Feb 2024 | GRANT_AWARD | LABCORP HOLDINGS INC. | 236 | 0.00 USD | deriv |
| 07 Feb 2024 | EXERCISE | LABCORP HOLDINGS INC. | 947 | 0.00 USD | deriv |
| 09 Jun 2023 | GRANT_AWARD | Tenaya Therapeutics, Inc. | 29,532 | 0.00 USD | deriv |
| 19 May 2023 | GRANT_AWARD | AMGEN INC | 939 | 0.00 USD | |
| 11 Feb 2023 | EXERCISE | LABCORP HOLDINGS INC. | 742 | — | |
| 11 Feb 2023 | EXERCISE | LABCORP HOLDINGS INC. | 742 | 0.00 USD | deriv |
| 07 Feb 2023 | GRANT_AWARD | LABCORP HOLDINGS INC. | 849 | 0.00 USD | deriv |
| 22 Aug 2022 | SALE | AMGEN INC | 200 | 249.96 USD | |
| 10 Jun 2022 | GRANT_AWARD | Tenaya Therapeutics, Inc. | 39,727 | 0.00 USD | deriv |
| 23 May 2022 | SALE | AMGEN INC | 600 | 250.00 USD | |
| 17 May 2022 | GRANT_AWARD | AMGEN INC | 855 | 0.00 USD | |
| 25 Mar 2022 | SALE | LABCORP HOLDINGS INC. | 572 | 272.98 USD | |
| 11 Feb 2022 | GRANT_AWARD | LABCORP HOLDINGS INC. | 742 | 0.00 USD | deriv |
| 02 Feb 2022 | EXERCISE | LABCORP HOLDINGS INC. | 771 | — | |
| 02 Feb 2022 | EXERCISE | LABCORP HOLDINGS INC. | 771 | 0.00 USD | deriv |
| 18 May 2021 | GRANT_AWARD | AMGEN INC | 837 | 0.00 USD | |
| 07 May 2021 | SALE | AMGEN INC | 250 | 251.78 USD | |
| 04 Feb 2021 | EXERCISE | LABCORP HOLDINGS INC. | 986 | — | |
| 04 Feb 2021 | EXERCISE | LABCORP HOLDINGS INC. | 986 | 0.00 USD | deriv |
| 08 Feb 2021 | SALE | AMGEN INC | 250 | 237.99 USD | |
| 02 Feb 2021 | GRANT_AWARD | LABCORP HOLDINGS INC. | 771 | 0.00 USD | deriv |